Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Monson

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Clinical Endocrinology|November 23, 2007
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumoursT T Chung, J Evanson, D Walker, et al.
Clinical Endocrinology|October 27, 2001
The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunningA Siddiqi, R R Foley, K E Britton, et al.
The American Journal of Surgical Pathology|April 11, 2000
'Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesisJ F Geddes, G H Jansen, S F Robinson, et al.
Hormone Research|December 7, 2007
Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapyA Colson, D Walker, G M Besser, et al.
Clinical Endocrinology|August 3, 2002
Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracilG A Kaltsas, J J Mukherjee, A Isidori, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International BoardB A Bengtsson, R Abs, H Bennmarker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. C Wüster, R Abs, B A Bengtsson, et al.
AJR. American Journal of Roentgenology|August 23, 2003
CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal glandR K Lingam, S A Sohaib, I Vlahos, et al.
European Journal of Endocrinology|June 29, 2002
Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 yearsC W le Roux, P J Jenkins, S L Chew, et al.
Immunogenetics|January 1, 1986
A DR3-related DX alpha gene polymorphism strongly associates with insulin-dependent diabetes mellitusG A Hitman, J Sachs, P Cassell, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Clinical Endocrinology|November 23, 2007
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumoursT T Chung, J Evanson, D Walker, et al.
Clinical Endocrinology|October 27, 2001
The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunningA Siddiqi, R R Foley, K E Britton, et al.
The American Journal of Surgical Pathology|April 11, 2000
'Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesisJ F Geddes, G H Jansen, S F Robinson, et al.
Hormone Research|December 7, 2007
Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapyA Colson, D Walker, G M Besser, et al.
Clinical Endocrinology|August 3, 2002
Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracilG A Kaltsas, J J Mukherjee, A Isidori, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International BoardB A Bengtsson, R Abs, H Bennmarker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. C Wüster, R Abs, B A Bengtsson, et al.
AJR. American Journal of Roentgenology|August 23, 2003
CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal glandR K Lingam, S A Sohaib, I Vlahos, et al.
European Journal of Endocrinology|June 29, 2002
Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 yearsC W le Roux, P J Jenkins, S L Chew, et al.
Immunogenetics|January 1, 1986
A DR3-related DX alpha gene polymorphism strongly associates with insulin-dependent diabetes mellitusG A Hitman, J Sachs, P Cassell, et al.
Pageof 18